OXFORD, England, July 8, 2021 /PRNewswire/ -- M Ventures – the strategic venture capital arm of Merck - joined the Theolytics' investor syndicate alongside Epidarex Capital and Taiho Ventures in an extension to the Series A financing, which includes additional investment from Taiho...

In this article

No tags related to this article.